Viewing Study NCT05034159


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2025-12-25 @ 2:04 PM
Study NCT ID: NCT05034159
Status: COMPLETED
Last Update Posted: 2023-05-18
First Post: 2021-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease
Sponsor: Dartmouth-Hitchcock Medical Center
Organization:

Study Overview

Official Title: A Pilot Trial of CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease
Status: COMPLETED
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SPIN
Brief Summary: People with Crohn's disease often suffer from sleep problems. Long term, sleep problems may lead to more flares of Crohn's disease or other complications. In general, people with Crohn's disease also report that sleep problems can worsen symptoms of Crohn's disease the next day. In people with other medical problems, research has also shown that having sleep problems can make other things worse, such as pain and inflammation. In this study, the researchers want to understand the treatment of sleep problems in people with Crohn's disease, and what else might improve if sleep gets better. This study will use Cognitive Behavioral Therapy for Insomnia (CBT-I) to treat insomnia symptoms. CBT-I is the recommended treatment for insomnia and has been shown to improve sleep problems, pain, and inflammation in other groups of people. If this study is successful, it will contribute to understanding how to treat insomnia in people with Crohn's disease and how sleep impacts pain and inflammation. Long term, this information will be helpful in understanding how best to take care of people with Crohn's disease.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: